Charles Moore,  —

Charles is a force to be reckoned with in the world of print and new media. From an interview with him in LowEndMac: ”His articles, features, and commentaries have appeared in more than 40 magazines, newspapers and websites in Canada, the US, the UK, and Australia. . . a columnist for The Halifax Daily News and the Saint John Telegraph Journal, Atlantic Fisherman, and news editor and columnist for Applelinks.com, a columnist and contributing editor for MacOpinion and PBCentral, as well as writing for Low End Mac.” Charles serves as the Senior Section Editor for the Science and Research section of BioNews Texas and contributes science-related articles on a daily basis.

Articles by Charles Moore

Cure SMA Grants More Than $2 Million in New Research Funding

Cure SMA granted just over $2 million in new research funding in 2015-16. The non-profit organization dedicated to advocacy and treatment research funding for spinal muscular atrophy (SMA), reports that the SMA drug development spectrum has expanded dramatically over the past decade, with six of the 18 programs currently in…

FightSMA Updates SMA Clinical Trials Status May 2016

FightSMA, an Richmond, Virginia, based all-volunteer, parent-led nonprofit, has released an update on the status of clinical trials it is currently supporting. Founded in 1991 by Joe and Martha Slay after their son Andrew was diagnosed with SMA (spinal muscular atrophy), with a mission to “strategically accelerate” research to…

Cure SMA and Cytokinetics Collaborate to Improve Disease Awareness, Treatment

Cure SMA of Elk Grove Village, Illinois, and biopharmaceutical company Cytokinetics Inc. of San Francisco, California, announced an expanded partnership to increase public awareness, education, and fund-raising efforts for spinal muscular atrophy (SMA). As a Cure SMA National Gold Partner, Cytokinetics will lend support to key national and local initiatives…